New pill aims to stop flare-ups in rare nerve disease
Disease control
Terminated
This study tested a daily pill called zanubrutinib in 6 adults with neuromyelitis optica spectrum disorder (NMOSD), a rare disease where the immune system attacks the optic nerves and spinal cord. The goal was to see if the drug could prevent relapses and reduce disability over 4…
Phase: PHASE2 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 17, 2026 12:05 UTC